跳至主要内容
临床试验/NCT03727282
NCT03727282Unknown不适用

Use of Transtoracic Ecocargiogram With Calculation of Left Ventricular Volume Index in the Initial Adjustment of Initial Dose of Dobutamine in Patients With Heart Failure and Cardiogenic Shock

University of Sao Paulo General Hospital0 个研究点目标入组 30 人开始时间: 2019年1月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
30
主要终点
cardiac output

研究概览

简要总结

Recent studies have suggested that the use of left ventricular ejection volume index calculation may aid in the hemodynamic management of critically ill patients. However, a prospective and randomized comparison in patients with heart failure for inotropic dose adjustment has not been described. The objective of this study was to evaluate the efficacy and safety of ejection volume index versus liberal strategy in adjusting dobutamine dose in patients with heart failure and low cardiac output. Methodology: A unicentric, randomized and prospective study will be performed in a comparative manner. Hospital data (test results, medical outcomes, dobutamine dose, complications) of patients will be analyzed for safety and effectiveness. Expected results: The use of ejection volume index is not inferior to the liberal strategy in the initial adjustment of the dose of dobutamine in patients with heart failure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • LVEF ≤ 40% documented on echocardiography
  • BNP> 500 pg / mL
  • Need for initiation of dobutamine and signs or symptoms of low cardiac output at admission defined by the presence of 2 or more of the following:
  • SBP ≤ 95 mmHg
  • FC> 100 bpm
  • Peripheral vasoconstriction,
  • Cold extremities,
  • Reference of decrease of urine output,
  • Nausea, vomiting and food intolerance,
  • Presence of organic dysfunction

排除标准

  • Pregnancy.
  • Hepatical cirrhosis
  • Atrioventricular block of 2nd or 3rd degree. and. SBP <80 mmHg or need for vasopressor.
  • Use of definitive pacemaker.
  • Body mass index greater than 40 kg / m
  • Use of oral anticoagulant.
  • Acute coronary syndrome.
  • Indication of use of another inotropic other than dobutamine.
  • Orotracheal intubation.
  • Presence of significant pericardial effusion.
  • Obstruction of left ventricular outflow tract.
  • Serum creatinine> 5.0 mg / dL or hemodialysis.
  • Presence of 2 or more clinical / laboratory / radiological criteria of infection

研究组 & 干预措施

Liberal strategy

Other

Initiate dobutamine at 5 mcg/kg/min and adjust dobutamine according to the attending physician

干预措施: adjust dobutamine according to the attending physician (Procedure)

ejection volume index

Experimental

Initiate dobutamine at 5 mcg/kg/min and adjust dobutamine according to the ejection volume index

干预措施: adjust dobutamine according to the ejection volume index (Procedure)

结局指标

主要结局

cardiac output

时间窗: 24 hours

echocardiography echocardiography

systolic and diastolic blood pressure

时间窗: 24 hours

physical evaluation

bicarbonate levels

时间窗: 24 hours

serum analysis

systolic volume

时间窗: 24 hours

echocardiography

central venous oxygen saturation levels

时间窗: 24 hours

serum analysis

heart rate

时间窗: 24 hours

physical evaluation

base excess levels

时间窗: 24 hours

serum analysis

arterial lactate levels

时间窗: 24 hours

serum analysis

creatinine levels

时间窗: 24 hours

serum analysis

urinary output

时间窗: 24 hours

urine analysis

urea levels

时间窗: 24 hours

serum analysis

BNP levels

时间窗: 24 hours

plasma analysis

troponin levels

时间窗: 24 hours

serum analysis

次要结局

  • worsening of renal function(24 hours)
  • occurrence of sustained ventricular arrhythmia(24 hours)
  • lowering of consciousness level(24 hours)
  • failure of dobutamine weaning up(7 days)
  • need for orotracheal intubation(24 hours)
  • cardiorespiratory arrest(24 hours)
  • need for vasopressor or other inotropic association(24 hours)
  • need for mechanical circulatory assistance(24 hours)
  • death(24 hours)
  • hospitalization time(30 days)

研究者

申办方类型
Other
责任方
Sponsor

相似试验